Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Genworth's Enact valued at $3.26 billion as share rise in Nasdaq debut

Published 09/16/2021, 01:16 PM
Updated 09/16/2021, 01:21 PM
© Reuters.

(Reuters) - Shares of Enact Holdings Inc, the mortgage insurance unit of insurer Genworth Financial Inc (NYSE:GNW), traded more than 5% higher in their Nasdaq debut on Thursday, giving it a valuation of $3.26 billion.

Shares opened at $20, compared to their initial public offering price (IPO) of $19 per share.

The debut comes after parent Genworth revived Enact's IPO earlier in the week. It had deferred the offering in May, citing excessive market volatility.

Genworth sold 13.3 million shares of Enact in the listing, raising about $253 million. Shares were priced at the bottom of the expected range of between $19 and $20 each. Proceeds from the sale of common stock will not go to Enact, and Genworth will continue to hold a majority position.

Investment management firm Bayview Asset Management also purchased 14.7 million shares of Enact's common stock in a private placement concurrent with the IPO. The stock had a value of $278.5 million, according to Reuters calculations based upon an Enact statement on Wednesday.

Genworth moved to list Enact after the parent firm's $2.7 billion buyout agreement with China Oceanwide Holdings Group Co, the investment firm of billionaire Lu Zhiqiang, fell through in April.

The deal, originally proposed in October 2016, stalled for years due to concerns over China's access to sensitive data on U.S. citizens.

Founded in 1981, Raleigh, North Carolina-based Enact provides credit protection to mortgage lenders and investors and operates in all 50 U.S. states and the District of Columbia.

Enact grew its net insurance policies written in 2020 to $99.9 billion, compared to $62.4 billion a year earlier. Its profit fell about 45% in the same period due to higher loss reserves related to the COVID-19 pandemic.

Goldman Sachs (NYSE:GS) and J.P. Morgan were the lead bookrunners for the offering.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.